GENEVA, Aug. 7 -- STARTON THERAPEUTICS, INC. filed a patent application (US2026/012289) for “CONTROLLED RELEASE DELIVERY OF LOW WATER SOLUBILITY COMPOUNDS VIA ORAL ADMINISTRATION”. With publication no. WO/2026/164922, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 9/20
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....